SCHEMBL473489

SCHEMBL473489

CC(C)c1ccccc1C(C)CC=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.40
GABRB2 P47870 2/20 0.40
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
TSHR P16473 2/20 0.37
FAAH O00519 2/20 0.37
LMNA P02545 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
HPGD P15428 1/20 0.37
GABRB1 P18505 1/20 0.37
PTGS1 P23219 1/20 0.37
SLC6A2 P23975 1/20 0.37
HTR2C P28335 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
HTR2B P41595 1/20 0.37
GABRA2 P47869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12290677 0.82 ESR1 (0.42) TSHRCA1CA2CYP3A4SLC6A2
SCHEMBL17755070 0.80 ADRB2 (0.42) TSHRLMNACYP1A2CYP3A4SLC6A2
SCHEMBL18726501 0.80 CYP3A4 (0.41) TSHRCYP3A4HIF1AKMT2AMEN1
SCHEMBL17755323 0.80 HTT (0.42) TSHRCYP3A4KMT2APOLBMEN1
SCHEMBL17754979 0.79 CA1 (0.44) CA1CA2L3MBTL1KMT2APOLB
SCHEMBL7678226 0.77 ALDH1A1 (0.46) CYP1A2
SCHEMBL4456482 0.77 ALDH1A1 (0.35) TSHRCA2CYP3A4
SCHEMBL28300884 0.77 ALDH1A1 (0.46) CYP1A2
SCHEMBL11490603 0.77 CA12 (0.39) CA1CA2KMT2ASMN1; SMN2CA12
SCHEMBL27889031 0.77 PNMT (0.35) TSHRHTR2CHTR2BSMN1; SMN2TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4516118-A2 USE OF AMBOCENIDE® FOR REINFORCING A LILY OF THE VALLEY NOTE Symrise AG (DE) 2025-03-05 EP claimed
US-20200239810-A1 USE OF AMBROCENIDE ® FOR INTENSIFYING A LILY OF THE VALLEY SCENT SYMRISE AG (DE) 2020-07-30 US claimed
EP-3665163-A1 USE OF AMBROCENIDE ® FOR INTENSIFYING A LILY OF THE VALLEY SCENT Symrise AG (DE) 2020-06-17 EP claimed
WO-2017174827-A1 USE OF AMBROCENIDE ® FOR INTENSIFYING A LILY OF THE VALLEY SCENT SYMRISE AG (DE) 2017-10-12 WO claimed
EP-1660621-B1 AGENTS THAT ARE ABSORBED BY THE SURFACE OF SUBSTRATES HENKEL AG & CO KGAA (DE) 2012-02-01 EP claimed
US-7446086-B2 Agents that are absorbed on the surfaces of substrates HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-11-04 US claimed
US-20060229230-A1 Agents that are absorbed on the surfaces of substrates HENKEL AG & CO. KGAA (DE) 2006-10-12 US claimed
EP-1660621-A1 AGENTS THAT ARE ABSORBED BY THE SURFACE OF SUBSTRATES Henkel Kommanditgesellschaft auf Aktien (DE) 2006-05-31 EP claimed
EP-0998911-B1 Fragrance releasing non-volatile polymeric siloxanes GEN ELECTRIC (US) 2006-05-17 EP claimed
WO-2005019400-A1 AGENTS THAT ARE ABSORBED BY THE SURFACE OF SUBSTRATES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2005-03-03 WO claimed
US-6153578-A Fragrance releasing olefinic silanes GENERAL ELECTRIC COMPANY (US) 2000-11-28 US claimed
US-6077923-A CONTAINING GROUPS OF FRAGRANT ESTERS, KETONES, OR ALDEHYDES GENERAL ELECTRIC COMPANY (US) 2000-06-20 US claimed
US-6075111-A A POLYSILOXANE HAVING ONE OR MORE SUBSTITUENTS SELECTED FROM A FRAGRANT ALDEHYDE, KETONE OR ESTER GENERAL ELECTRIC COMPANY (US) 2000-06-13 US claimed
EP-0998911-A2 Fragrance releasing non-volatile polymeric siloxanes GENERAL ELECTRIC COMPANY (US) 2000-05-10 EP claimed
EP-0982313-A2 Fragrance releasing olefinic silanes GENERAL ELECTRIC COMPANY (US) 2000-03-01 EP claimed
EP-3883927-B1 AMBER ODORANT FIRMENICH & CIE (CH) 2025-10-01 EP disclosed
EP-4516118-A2 USE OF AMBOCENIDE® FOR REINFORCING A LILY OF THE VALLEY NOTE Symrise AG (DE) 2025-03-05 EP disclosed
US-6046156-A Fragrance releasing olefinic silanes GENERAL ELECTRIC COMPANY (US) 2000-04-04 US disclosed
EP-0982023-A2 Emulsions of fragrance releasing silicon compounds GENERAL ELECTRIC COMPANY (US) 2000-03-01 EP disclosed
EP-0982313-A2 Fragrance releasing olefinic silanes GENERAL ELECTRIC COMPANY (US) 2000-03-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200239810-A1 USE OF AMBROCENIDE ® FOR INTENSIFYING A LILY OF THE VALLEY SCENT OR51E2, OR10J3, ALG3 GABRA1 86/4885GABRB2 94/4885GABRG2 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.